Array
(
[Ovarian Cancer] => Array
(
[Austin] => https://www.survivornet.com/austin/
[Baltimore] => https://www.survivornet.com/baltimore/
[Charlotte] => https://www.survivornet.com/charlotte/
[Cleveland] => https://www.survivornet.com/cleveland/
[Columbus] => https://www.survivornet.com/columbus/
[Dallas / Ft. Worth] => https://www.survivornet.com/dallas-ftworth/
[Denver] => https://www.survivornet.com/denver/
[Detroit] => https://www.survivornet.com/detroit/
[Indianapolis] => https://www.survivornet.com/indianapolis-ovarian-cancer/
[Louisville] => https://www.survivornet.com/louisville/
[Memphis] => https://www.survivornet.com/memphis/
[Minneapolis] => https://www.survivornet.com/minneapolis/
[Nashville] => https://www.survivornet.com/nashville/
[Phoenix] => https://www.survivornet.com/phoenix/
[Portland] => https://www.survivornet.com/portland/
[Salt Lake City] => https://www.survivornet.com/salt-lake-city/
[San Antonio] => https://www.survivornet.com/san-antonio/
[San Diego] => https://www.survivornet.com/san-diego/
[San Francisco] => https://www.survivornet.com/san-francisco/
[San Jose] => https://www.survivornet.com/san-jose/
[Seattle] => https://www.survivornet.com/seattle/
) [Multiple Myeloma] => Array
(
[Ann Arbor] => https://www.survivornet.com/ann-arbor-michigan-multiple-myeloma-treatment/
[Miami] => https://www.survivornet.com/miami-florida-multiple-myeloma-treatment/
[Phoenix] => https://www.survivornet.com/phoenix-arizona-multiple-myeloma-treatment/
) [Glioma] => Array
(
[Midwest] => https://www.survivornet.com/midwest/
[Mountain States] => https://www.survivornet.com/glioma-mountain-states/
[Southeast] => https://www.survivornet.com/southeast/
) )
A Study of SU11248 In Patients With Metastatic Breast Cancer Who Have Failed Selected Other Therapies.
Summary
Assessment of safety and efficacy of SU11248 in patients with metastatic breast cancer who have failed selected other therapies.
View Eligibility CriteriaEligibility Criteria
Inclusion Criteria:
Anthracycline and taxane-refractory or intolerant metastatic breast cancer
Female
Exclusion Criteria:
Prior treatment with 3 or greater regimens of chemotherapy in the advanced/metastatic disease setting beyond those containing anthracyclines/taxanes.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There are 10 Locations for this study
Pfizer Investigational Site
Greenbrae California, 94904, United States
Pfizer Investigational Site
Los Angeles California, 90095, United States
Pfizer Investigational Site
San Francisco California, 94115, United States
Pfizer Investigational Site
Aurora Colorado, 80010, United States
Pfizer Investigational Site
Chicago Illinois, 60612, United States
Pfizer Investigational Site
Indianapolis Indiana, 46202, United States
Pfizer Investigational Site
Baltimore Maryland, 21231, United States
Pfizer Investigational Site
Boston Massachusetts, 02114, United States
Pfizer Investigational Site
Boston Massachusetts, 02115, United States
Pfizer Investigational Site
Boston Massachusetts, 02215, United States
How clear is this clinincal trial information?
Sign Up
Sign up now for access to powerful tools, top experts, and customized information to help you fight cancer.
- Personalized content tailored to your profile and disease type
- Access exclusive patient guides
- Breaking treatment information and expert perspectives
- and more...
Already have an account? Sign In
Sign Up
Already have an account? Sign In
Sign In
Don't have an account? Sign Up
Password reset is unavailable because your account was created using 'Sign Up with Google.
To continue, please use the Google sign-in button below.
Don't have an account? Sign Up